Aimfinity Investment Corp. I modifies underwriter payment terms

Published 18/06/2025, 15:50
Aimfinity Investment Corp. I modifies underwriter payment terms

Aimfinity Investment Corp. I (AIMUF), currently valued at $48.49 million in market capitalization, announced Wednesday that it has entered into agreements with its IPO underwriters to modify their deferred compensation arrangements ahead of its pending business combination with Docter Inc. According to InvestingPro data, the company’s stock has declined 22.66% year-to-date, reflecting market uncertainty around the transaction.

Under the new agreements signed June 13, underwriters D. Boral (OTC:BOALY) Capital LLC and US Tiger Securities will each receive $80,000 in cash plus 132,875 ordinary shares of the post-merger company at closing, instead of their original $2.8 million cash deferred commission. This restructuring comes as InvestingPro analysis indicates a WEAK financial health score of 1.7, suggesting the company may be prioritizing cash preservation.

The agreements include price protection mechanisms that would provide additional shares or cash if the stock trades below the agreed $10 per share value when a registration statement for these shares is filed. The underwriter shares will be registered within 30 days after the business combination closes.

The company also provided an update on its pro forma financial position, estimating shareholders’ equity of approximately $4.02 million as of June 30, 2025, after accounting for redemptions of 1,072,957 shares and various debt conversions. CEO I-Fa Chang will convert approximately $2.6 million in extension and working capital loans into equity at closing.

The business combination with Docter Inc., which was approved by shareholders on March 27, involves a reincorporation merger and acquisition merger. The transaction includes additional equity issuances to settle various outstanding obligations.

The agreements with the underwriters will only take effect if the business combination with Docter is completed.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.